Chipre - grego - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

fair-med healthcare gmbh - valsartan, hydrochlorothiazide - film coated tablets - 80mg/12.5mg - 8000001531 - valsartan - 80 mg; 0000058935 - hydrochlorothiazide - 12.5 mg - valsartan and diuretics

Chipre - grego - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

fair-med healthcare gmbh - valsartan, hydrochlorothiazide - film coated tablets - 160mg/12.5mg - 8000001531 - valsartan - 160 mg; 0000058935 - hydrochlorothiazide - 12.5 mg - valsartan and diuretics

União Europeia - grego - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Αντινεοπλασματικοί παράγοντες - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.